The Dawn of a New Era in Mental Health Treatment: Clearmind Medicine's Revolutionary Psychedelic Compounds. Clearmind Medicine Inc., has recently announced an exclusive licensing agreement that could fundamentally transform the landscape of mental health therapy. This partnership with Yissum Research Development Company of the Hebrew University of Jerusalem heralds the arrival of generation 3.0 psychedelic...
$クリアマインド・メディシン(CMND.US)$Clearmind Medicine Announces Exclusive Licensing Agreement for Generation 3.0 Psychedelic Compounds for the Treatment of Mental Disorders
$クリアマインド・メディシン(CMND.US)$Clearmind Medicine Announced That It Has Filed A Patent Application With United States Patent And Trademark Office For Psychedelic-based Treatment For Eating Disorders
$クリアマインド・メディシン(CMND.US)$Clearmind Medicine CEO Issues Letter To Shareholders; Says Poised To Achieve Significant Milestones That It Hopes To Substantially Enhance Shareholder Value Through 2024
クリアマインド・メディシンに関するコメント
Biotechnology Company Announces Exclusive Licensing Agreement For Mental Disorder Treatment
Clearmind Medicine Inc., has recently announced an exclusive licensing agreement that could fundamentally transform the landscape of mental health therapy. This partnership with Yissum Research Development Company of the Hebrew University of Jerusalem heralds the arrival of generation 3.0 psychedelic...
Update
Update
Interesting !
Update
Benzinga· 2 mins ago
まだコメントはありません